{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:59:18Z","timestamp":1771581558459,"version":"3.50.1"},"reference-count":41,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.3201\/eid2002.130611","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T14:06:45Z","timestamp":1389967605000},"source":"Crossref","is-referenced-by-count":44,"title":["Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women"],"prefix":"10.3201","volume":"20","author":[{"given":"Dana","family":"Meaney-Delman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne E.","family":"Zotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea A.","family":"Creanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara K.","family":"Misegades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etobssie","family":"Wako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracee A.","family":"Treadwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Messonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise J.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Workgroup on Anthrax in Pregnant and Postpartum Women","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2002.130611-201401170906-R1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2002.130611-201401170906-R2","unstructured":"Institute of Medicine. Prepositioning antibiotics for anthrax. 2011 Sept [cited 2012 Feb 9]. http:\/\/www.iom.edu\/Reports\/2011\/Prepositioning-Antibiotics-for-Anthrax.aspx"},{"key":"key-10.3201\/eid2002.130611-201401170906-R3","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.ajog.2005.06.062","article-title":"Emerging infectious disease outbreaks: old lessons and new challenges for obstetrician-gynecologists.","volume":"194","author":"Jamieson","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/AOG.0b013e318270ec08","article-title":"Anthrax cases in pregnant and postpartum women: a systematic review.","volume":"120","author":"Meaney-Delman","year":"2012","journal-title":"Obstet Gynecol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/AOG.0b013e3182a5fdfd","article-title":"Safety and pharmacokinetics of antibiotics used for anthrax prophylaxis and treatment: a systematic review.","volume":"12294","author":"Meaney-Delman","year":"2013","journal-title":"Obstet Gynecol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3201\/eid1404.070969","article-title":"Conference report on public health and clinical guidelines for anthrax.","volume":"14","author":"Stern","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2002.130611-201401170906-R7","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.","volume":"59","author":"Wright","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid2002.130611-201401170906-R8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3201\/eid2002.130687","article-title":"Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults.","volume":"20","author":"Hendricks","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2002.130611-201401170906-R9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/aje\/kwn159","article-title":"Birth defects among infants born to women who received anthrax vaccine in pregnancy.","volume":"168","author":"Ryan","year":"2008","journal-title":"Am J Epidemiol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.11.024","article-title":"Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels","volume":"204","author":"Gall","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R11","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants.","volume":"359","author":"Zaman","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2002.130611-201401170906-R12","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/AOG.0b013e3182148efe","article-title":"Efficacy of an accelerated hepatitis B vaccination program during pregnancy.","volume":"117","author":"Sheffield","year":"2011","journal-title":"Obstet Gynecol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/INF.0b013e3182093814","article-title":"Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants.","volume":"30","author":"Leuridan","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2002.130611-201401170906-R14","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1016\/j.vaccine.2007.03.021","article-title":"Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies.","volume":"25","author":"Quiambao","year":"2007","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2002.130611-201401170906-R15","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3201\/eid1211.060618","article-title":"Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies.","volume":"12","author":"Cono","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2002.130611-201401170906-R16","unstructured":"Cipro [package insert]. West Haven (CT): Bayer Healthcare; 2004."},{"key":"key-10.3201\/eid2002.130611-201401170906-R17","doi-asserted-by":"publisher","first-page":"e1034","DOI":"10.1542\/peds.2011-1496","article-title":"The use of systemic and topical fluoroquinolones.","volume":"128","author":"Bradley","year":"2011","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid2002.130611-201401170906-R18","unstructured":"Ciprofloxacin (Reprotext document). In: Klasco RK, editor. Reprotext database, version 5.1. Greenwood Village (CO): Thomson Micromedex; 2012."},{"key":"key-10.3201\/eid2002.130611-201401170906-R19","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/01.AOG.0000216197.26783.b5","article-title":"Antibiotic use in pregnancy and lactation: What is and is not known about teratogenic and toxic risks.","volume":"107","author":"Nahum","year":"2006","journal-title":"Obstet Gynecol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R20","unstructured":"Vibramycin hyclate (doxycyline hyclate capsules, USP) [package insert]. New York: Pfizer Laboratories; 2007."},{"key":"key-10.3201\/eid2002.130611-201401170906-R21","unstructured":"Doxycycline (Reprotext document). In: Klasco RK, editor. Reprotext database, version 5.1. Greenwood Village (CO); Thomson Micromedex; 2012."},{"key":"key-10.3201\/eid2002.130611-201401170906-R22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7326\/0003-4819-144-4-200602210-00009","article-title":"Systematic review: a century of inhalational anthrax cases from 1900 to 2005.","volume":"144","author":"Holty","year":"2006","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid2002.130611-201401170906-R23","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","article-title":"Postexposure prophylaxis against experimental inhalation anthrax.","volume":"167","author":"Friedlander","year":"1993","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2002.130611-201401170906-R24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0301-2115(95)02524-3","article-title":"Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS).","volume":"69","author":"Schaefer","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0002-9343(87)90614-0","article-title":"Norfloxacin: review of safety studies.","volume":"82","author":"Corrado","year":"1987","journal-title":"Am J Med"},{"key":"key-10.3201\/eid2002.130611-201401170906-R26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/tera.1420460507","article-title":"Embryotoxicity studies of norfloxacin in cynomolgus monkeys. II. Role of progesterone.","volume":"46","author":"Cukierski","year":"1992","journal-title":"Teratology"},{"key":"key-10.3201\/eid2002.130611-201401170906-R27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccl.2012.05.002","article-title":"Cardiovascular imaging and diagnostic procedures in pregnancy.","volume":"30","author":"Ain","year":"2012","journal-title":"Cardiol Clin"},{"key":"key-10.3201\/eid2002.130611-201401170906-R28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ccl.2012.05.004","article-title":"Physiologic changes during normal pregnancy and delivery.","volume":"30","author":"Ouzounian","year":"2012","journal-title":"Cardiol Clin"},{"key":"key-10.3201\/eid2002.130611-201401170906-R29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/AOG.0b013e3181993087","article-title":"Practice Bulletin no. 100: critical care in pregnancy.","volume":"113","author":"American College of Obstetrics and Gynecology","year":"2009","journal-title":"Obstet Gynecol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.ajog.2006.05.042","article-title":"Intensive care in obstetrics: An evidence-based review.","volume":"195","author":"Martin","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R31","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1097\/AOG.0b013e31825af2f0","article-title":"Practice Bulletin no. 127: management of preterm labor.","volume":"119","author":"American College of Obstetrics and Gynecology","year":"2012","journal-title":"Obstet Gynecol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R32","unstructured":"Raxibacumab [package insert]. Research Triangle Park (NC): GlaxoSmithKline; 2012."},{"key":"key-10.3201\/eid2002.130611-201401170906-R33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/10408444.2011.653487","article-title":"The placenta, transfer of immunoglobulins, and safety assessment of biopharmaceuticals in pregnancy.","volume":"42","author":"DeSesso","year":"2012","journal-title":"Crit Rev Toxicol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R34","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1067\/mai.2001.117821","article-title":"Obstetric uses of intravenous immunoglobulin: successes, failures, and promises.","volume":"108","author":"Branch","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R35","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1016\/j.ajog.2011.04.011","article-title":"Predictors of H1N1 vaccination in pregnancy.","volume":"204","author":"Fridman","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R36","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R37","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/QAI.0b013e31822f8914","article-title":"Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1\u2013infected pregnant women and their infants in Kampala, Uganda (HIVIGLOBb\/NVP study).","volume":"58","author":"Onyango-Makumbi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.3201\/eid2002.130611-201401170906-R38","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/S0002-9378(96)70582-3","article-title":"Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin.","volume":"174","author":"Bussel","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.3201\/eid2002.130611-201401170906-R39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/rheumatology\/ken046","article-title":"Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.","volume":"47","author":"Perricone","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"key-10.3201\/eid2002.130611-201401170906-R40","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/humrep\/der227","article-title":"A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories.","volume":"26","author":"Ensom","year":"2011","journal-title":"Hum Reprod"},{"key":"key-10.3201\/eid2002.130611-201401170906-R41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jiph.2010.07.004","article-title":"A review of cutaneous anthrax and its outcome.","volume":"3","author":"Doganay","year":"2010","journal-title":"J Infect Public Health"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/20\/2\/13-0611_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:24:48Z","timestamp":1733286288000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/20\/2\/13-0611_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2002.130611","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}